Magenta has also begun to explore MGTA-145's utility in the gene therapy market, having already partnered with Beam therapeutics (NASDAQ:BEAM) ...
https://www.google.com/url?rct=j&sa=t&url=https://www.fool.com/investing/2021/02/27/magenta-is-ready-to-paint-your-portfolio-green/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFr4FtyT4CD8t4oXDiTwyKEu6mEIA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.